ANTIGEN-DEPENDENT, H-2-RESTRICTED CYTOLYTIC AND NONCYTOLYTIC T CELL LINES WITH SPECIFICITY FOR MINOR HISTOCOMPATIBILITY ANTIGENSDI PAULI R; OPALKA B.1982; EUR. J. IMMUNOL.; ISSN 0014-2980; DEU; DA. 1982; VOL. 12; NO 5; PP. 365-373; BIBL. 18 REF.Article

THE ANAEROBIC METABOLISM OF THE LARVAE OF THE MIDGE CHAOBORUS CRYSTALLINUSENGLISCH H; OPALKA B; ZEBE E et al.1982; INSECT BIOCHEM.; GBR; DA. 1982; VOL. 12; NO 2; PP. 149-155; BIBL. 28 REF.Article

Interferon alfa as primary treatment of chronic myeloid leukemia : long-term follow-up of 71 patients observed in a single centerKLOKE, O; OPALKA, B; NIEDERLE, N et al.Leukemia. 2000, Vol 14, Num 3, pp 389-392, issn 0887-6924Article

Analysis of inversions and sister chromatid exchanges in chromosome 3 of human lymphocytes exposed to X-raysWOJCIK, A; OPALKA, B; OBE, G et al.Mutagenesis. 1999, Vol 14, Num 6, pp 633-637, issn 0267-8357Article

A simple and cheap device for gradient formationDREYER, K; OPALKA, B; SCHULTE-HOLTHAUSEN, H et al.Nucleic acids research. 1991, Vol 19, Num 6, issn 0305-1048, p. 1348Article

Assignment of human filamin gene FLNB to human chromosome band 3p14.3 and identification of YACs containing the complete FLNB transcribed regionBRÖCKER, F; BARDENHEUER, W; VIETEN, L et al.Cytogenetics and cell genetics. 1999, Vol 85, Num 3-4, pp 267-268, issn 0301-0171Article

Frequency of clonal B lymphocytes in chronic myelogenous leukemia evaluated by fluorescence in situ hybridizationAL-AMIN, A; LENNARTZ, K; RUNDE, V et al.Cancer genetics and cytogenetics. 1998, Vol 104, Num 1, pp 45-47, issn 0165-4608Article

Report of the sixth international workshop on human chromosome 3 mapping 1995NAYLOR, S. L; CARRITT, B; BUYS, C. H. C. M et al.Cytogenetics and cell genetics. 1996, Vol 72, Num 4, pp 255-270, issn 0301-0171Conference Paper

Characterization and chromosomal assignment of yeast artificial chromosomes containing human 3p13-p21-specific sequence tagged sitesMICHAELIS, S. C; BARDENHEUER, W; BUYS, C. H. C. M et al.Cancer genetics and cytogenetics. 1995, Vol 81, Num 1, pp 1-12, issn 0165-4608Article

Altered host range phenotype of the transformation-defective Ad12 mutant CS-1 is due to deletions in the E1 regionOPALKA, B; REITH-WITOWSKI, M; KIRCH, H.-C et al.Intervirology. 1994, Vol 37, Num 1, pp 36-40, issn 0300-5526Article

Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatmentWANDL, U. B; BÜTZLER, R; NIEDERLE, N et al.Leukemia. 1994, Vol 8, Num 5, pp 776-779, issn 0887-6924Article

The p44^S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanomaSONGRONG REN; SMITH, M. J; SMITH, D. I et al.Oncogene (Basingstoke). 2000, Vol 19, Num 11, pp 1419-1427, issn 0950-9232Article

Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expressionWERNER, N. S; SIPRASHVILI, Z; FONG, L. Y. Y et al.Cancer research (Baltimore). 2000, Vol 60, Num 11, pp 2780-2785, issn 0008-5472Article

Genetic instability of 3p12-p21-specific microsatellite sequences in renal cell carcinomaWILLERS, C. P; SIEBERT, R; BARDENHEUER, W et al.British journal of urology (Print). 1996, Vol 77, Num 4, pp 524-529, issn 0007-1331Article

Prolonged administration of interferon-α in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcomeBEELEN, D. W; GRAEVEN, U; ELMAAGACLI, A. H et al.Blood. 1995, Vol 85, Num 10, pp 2981-2990, issn 0006-4971Article

Tumor necrosis factor α modifies resistance to interferon α in vivo : first clinical dataMORITZ, T; KLOKE, O; NAGEL-HIEMKE, M et al.Cancer immunology and immunotherapy. 1992, Vol 35, Num 5, pp 342-346, issn 0340-7004Article

Identification of novel 'expressed sequence tags' within the FHIT gene locus in human chromosome region 3p14.2LUX, A; BARDENHEUER, W; MICHAEL, D et al.Human genetics. 1997, Vol 100, Num 1, pp 90-95, issn 0340-6717Article

Analysis of the p53 gene in patients with isochromosome 17q and Ph¹-positive or -negative myeloid leukemiaSCHÜTTE, J; OPALKA, B; BECHER, R et al.Leukemia research. 1993, Vol 17, Num 6, pp 533-539, issn 0145-2126Article

Breakpoint localization within the M-bcr and clinial course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapyOPALKA, B; WANDL, U; BEER, U et al.Leukemia. 1991, Vol 5, Num 6, pp 452-456, issn 0887-6924Article

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon α-2b alone or in combination with interferon γOPALKA, B; WANDL, U. B; BECHER, R et al.Blood. 1991, Vol 78, Num 9, pp 2188-2193, issn 0006-4971Article

DNA-flow cytometry studies in blood and marrow cells from chronic myelogenous leukemia patients treated with interferon alpha-2bWANDL, U. B; MAY, D; PELTZER, T et al.Leukemia research. 1990, Vol 14, Num 10, pp 905-908, issn 0145-2126, 4 p.Article

Treatment of chronic myelogenous leukemia with interferons alpha and gammaKLOKE, O; MAY, D; WANDL, U et al.Blut. 1990, Vol 61, Num 1, pp 45-46, issn 0006-5242, 2 p.Article

Definition of a region required for transformation in E1 of adenovirus 12MURPHY, M; OPALKA, B; SAJACZKOWSKI, R et al.Virology (New York, NY). 1987, Vol 159, Num 1, pp 49-56, issn 0042-6822Article

The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stageELMAAGACLI, A. H; BEELEN, D. W; OPALKA, B et al.Annals of hematology (Print). 2000, Vol 79, Num 8, pp 424-431, issn 0939-5555Article

Limited heterogeneity or rearranged T cell receptor V_α and V_β transcripts in synovial fluid T cells in early stages of rheumatoid arthritisFISCHER, D.-C; OPALKA, B; HOFFMANN, A et al.Arthritis and rheumatism. 1996, Vol 39, Num 3, pp 454-462, issn 0004-3591Article